Lilly, Sanofi, Novartis, Bayer deny wrongdoing, claim Indian report 'inaccurate'
This article was originally published in Scrip
Executive Summary
Days after an Indian parliamentary committee report alleged a series of serious regulatory lapses in approving drugs for launch in the country, half a dozen leading companies named in the report including Lilly, Sanofi, Novartis, Bayer and Cipla claim that they have not flouted Indian laws and deny any wrongdoing.